Aquilo Capital, L.P.'s Form 4 filing
Spero Therapeutics, Inc. (SPRO) · filed Aug 27, 2021
- Accession no.
- 0001591986-21-000011
- Filed
- Aug 27, 2021, 5:11 PM ET
- Trade date
- Aug 26-27, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $615.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aquilo Capital, L.P.CIK 0001491371 | 10% Owner |
| Aquilo Capital Management, LLCCIK 0001591986 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2021 | Common Stock, $0.001 par value | PPurchaseAcquired | +22,982 | $16.55 | +$380,322.22 | 4,251,386 | Indirect | |
| Aug 27, 2021 | Common Stock, $0.001 par value | PPurchaseAcquired | +13,957 | $16.88 | +$235,531.35 | 4,265,343 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.